Larry L Wood Edwards Lifesciences Corp (EW) insider trading activity

Larry L Wood is Global President TAVR & Surg of Edwards Lifesciences Corp. Currently has a direct ownership of 206,900 shares of EW, which is worth approximately $16.2 Million. The most recent transaction as insider was on Aug 14, 2023, when has been sold 6,421 shares (Common Stock) at a price of $45.28 per share, resulting in proceeds of $290,742. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 207K

4.39% 3M change

7.44% 12M change

Total Value Held $16.2 Million

Larry L Wood Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2023	BUY Exercise of conversion of derivative security	$290,742 $45.28 p/Share	6,421 Added 2.83%	220,214 Common Stock
Jul 14 2023	SELL Open market or private sale	$804,860 $92.94 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Jul 14 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
Jun 14 2023	SELL Open market or private sale	$781,911 $90.29 p/Share	8,660 Reduced 3.89%	213,793 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	$392,124 $45.28 p/Share	8,660 Added 3.75%	222,453 Common Stock
May 24 2023	SELL Open market or private sale	$540,840 $84.23 p/Share	6,421 Reduced 2.92%	213,793 Common Stock
May 24 2023	BUY Exercise of conversion of derivative security	$290,742 $45.28 p/Share	6,421 Added 2.83%	220,214 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	7,775 Added 3.51%	213,793 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$130,625 $88.74 p/Share	1,472 Reduced 0.71%	206,310 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$229,215 $88.74 p/Share	2,583 Reduced 1.23%	207,782 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	5,415 Added 2.51%	210,365 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$34,887 $88.1 p/Share	396 Reduced 0.19%	204,950 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$33,631 $87.81 p/Share	383 Reduced 0.19%	205,346 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	3,235 Added 1.55%	205,466 Common Stock
Dec 13 2022	SELL Open market or private sale	$558,763 $77.22 p/Share	7,236 Reduced 3.45%	202,231 Common Stock
Dec 13 2022	BUY Exercise of conversion of derivative security	$265,923 $36.75 p/Share	7,236 Added 3.34%	209,467 Common Stock
Nov 08 2022	SELL Open market or private sale	$496,077 $68.5 p/Share	7,242 Reduced 3.46%	202,231 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$266,143 $36.75 p/Share	7,242 Added 3.34%	209,473 Common Stock
Oct 11 2022	SELL Open market or private sale	$594,713 $82.12 p/Share	7,242 Reduced 3.46%	202,231 Common Stock
Oct 11 2022	BUY Exercise of conversion of derivative security	$266,144 $36.75 p/Share	7,242 Added 3.34%	209,473 Common Stock
Sep 06 2022	SELL Open market or private sale	$644,538 $89.0 p/Share	7,242 Reduced 3.46%	202,231 Common Stock
Sep 06 2022	BUY Exercise of conversion of derivative security	$266,144 $36.75 p/Share	7,242 Added 3.34%	209,473 Common Stock
Aug 09 2022	SELL Open market or private sale	$759,034 $104.81 p/Share	7,242 Reduced 3.46%	202,231 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	$266,144 $36.75 p/Share	7,242 Added 3.34%	209,473 Common Stock
Jul 05 2022	SELL Open market or private sale	$694,508 $95.9 p/Share	7,242 Reduced 3.46%	202,231 Common Stock

Also insider at

PRCT

PROCEPT BioRobotics Corp Healthcare

Director

LLW

Larry L Wood

Global President TAVR & Surg

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account